even with the bio med space considerably down in an inflationary environment the stock price being far lower than when it was a phase 2 company I believe comes down to $40m cash left. Different story if they had 150m in bank ready for years of trials ahead. my views.
even with the bio med space considerably down in an inflationary...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $30.85K | 119.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7444 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 6787 | 6 |
View Market Depth
| Last trade - 11.14am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
0.010 ( 4.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 26.0¢ | 24.5¢ | 24814 | ||
| Last updated 11.26am 06/05/2024 ? | |||||
| PAR (ASX) Chart |